0000885590-12-000075.txt : 20121109
0000885590-12-000075.hdr.sgml : 20121109
20121109155326
ACCESSION NUMBER: 0000885590-12-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121108
FILED AS OF DATE: 20121109
DATE AS OF CHANGE: 20121109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DE SILVA RAJIV
CENTRAL INDEX KEY: 0001453140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 121193577
MAIL ADDRESS:
STREET 1: 4787 LEVY STREET
CITY: MONTREAL
STATE: A8
ZIP: H4R 2P9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2012-11-08
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001453140
DE SILVA RAJIV
4787 LEVY STREET
MONTREAL
A8
H4R 2P9
QUEBEC, CANADA
0
1
0
0
Pres & COO, Specialty Pharm
Common Stock, no par value
2012-11-08
4
M
0
76344
25.42
A
341561
D
Common Stock, no par value
2012-11-08
4
S
0
76344
54.0406
D
265217
D
Non-Qualified Stock Options (right to purchase)
25.42
2012-11-08
4
M
0
76344
0
D
2012-10-08
2015-11-11
Common Stock, no par value
76344
96136
D
This number represents the weighted average sale price for all sales of common stock sold by the reporting officer. The actual sale prices range from $54.00 to $54.34. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.
This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.
by: Nicholas Zanoni for Rajiv De Silva
2012-11-09